SteerBio

SteerBio

Martha Fowler, Ph.D. ‘25, Bioengineering | Mor Sela Golan | Alvaro Moreno Lozano

SteerBio is a biotechnology company pioneering regenerative therapies for the lymphatic system and disease. Our mission is simple yet ambitious: to transform lymphatic disease care from chronic management to true restoration of the lymphatics.

Website | LinkedIn

Sector

Health Tech

---

Lilie Connection

Rice Innovation Fellows, NRLC Second Place Winner 2025

---

Press Links

RBL LLC Announces Launch of SteerBio with an up to $18.2 Million Federal Award to Pioneer a Curative Therapy for Lymphedema

Steer Bio Targets Lymphedema with Regenerative Cell Therapy Platform